Surmodics Investor Relations Material
Latest events
Q2 2024
Surmodics
Q3 2025
8 Aug, 2025
Q2 2025
30 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Surmodics Inc
Access all reports
Surmodics Inc. is a provider of medical device and in vitro diagnostic technologies. The company develops surface modification coatings, drug delivery technologies, and diagnostic components. Its products are used by medical device manufacturers and diagnostic test developers, particularly in cardiovascular and peripheral vascular applications. Surmodics also offers contract research and development services. The company is headquartered in Eden Prairie, Minnesota, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
SRDX
Country
🇺🇸 United States